Published in Cancer Weekly, September 11th, 2007
The Prostate Cancer Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis and staging, and an overview of treatments for localized disease, locally and regionally advanced disease, and metastatic disease. Dosing information is provided for LHRH agonists, anti-androgens, and chemotherapy. General information on sales of prostate cancer therapies worldwide, as well as for LHRH agonists and anti-androgens is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.